Preterm premature rupture of membranes: management between 28 and 34 weeks of pregnancy

Main Article Content

Isabela Cason
https://orcid.org/0000-0001-6688-1160
Chayene Aguiar Rocha
Rosely Erlach Goldman

Abstract

Introduction: Premature rupture of membranes remains a challenge for professionals due to the high rates of maternal and neonatal morbidity and mortality, mainly related to complications resulting from prematurity. Objective: To analyze the scientific production about premature rupture of membranes in pregnancies above 28 weeks and below 34 weeks. Methods: Integrative literature review carried out in the Lilacs, SciELO, Medline and Cochrane Library databases, between 2014 and 2018, in Portuguese, English and Spanish, including original articles, available in full online, with free access, that addressed the study theme, using the keywords "premature rupture of ovular membranes", "premature labor" and "pregnancy complications" combined using the Boolean operators "AND" and "OR". Results: Fourteen studies were included. It was possible to highlight the main recommendations regarding preterm premature rupture of membranes, divided into six categories for discussion, namely: indications for expectant management and delivery induction, prophylactic antibiotic therapy, prenatal corticosteroids, use of tocolytics, recommendations regarding the use of magnesium sulfate and amniocentesis. Conclusion: It was identified that expectant management is the ideal approach, with constant monitoring of the pregnant woman and the fetus, in addition to the administration of prophylactic antibiotics and prenatal corticosteroids, in the face of premature rupture of membranes in pregnancies between 28 and 34 weeks in order to provide the best maternal and perinatal results, guiding health professionals to evidence-based practice.

Downloads

Download data is not yet available.

Article Details

How to Cite
Cason, I., Rocha, C. A., & Goldman, R. E. (2021). Preterm premature rupture of membranes: management between 28 and 34 weeks of pregnancy. ABCS Health Sciences, 46, e021309. https://doi.org/10.7322/abcshs.2020149.1600
Section
Review Articles
Author Biographies

Isabela Cason, Escola Paulista de Enfermagem, Universidade Federal de São Paulo (UNIFESP) – São Paulo (SP), Brazil

Enfermeira graduada pela Universidade Federal de São Paulo – UNIFESP. São Paulo – Brasil.

Chayene Aguiar Rocha, Escola Paulista de Enfermagem, Universidade Federal de São Paulo (UNIFESP) – São Paulo (SP), Brazil

Enfermeira graduada pela Universidade Federal de São Paulo – UNIFESP. São Paulo – Brasil.

Rosely Erlach Goldman, Departamento de Enfermagem na Saúde da Mulher, Escola Paulista de Enfermagem, UNIFESP – São Paulo (SP), Brazil

Enfermeira Obstetra, Pós-Doutorado pela Escola Paulista de Enfermagem da Universidade Federal de São Paulo e Professora associada da Escola Paulista de Enfermagem, Universidade Federal de São Paulo, São Paulo – Brasil.

References

1. Galletta MAK. Rotura prematura das membranas ovulares: protocolo clínico. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia, 2018.

2. Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 188: Prelabor Rupture of Membranes. Obstetr Gynecol. 2018;131(1). http://doi.org/10.1097/AOG.0000000000002455

3. Téllez DA, Ramírez S, Parada NS, Fernández-Niño JA. Inducción del parto versus manejo expectante en ruptura prematura de membranas pretérmino: revisión sistemática y metanálisis. Rev Univ Ind Santander Salud. 2017;49(1):45-55. http://dx.doi.org/10.18273/revsal.v49n1-2017005

4. Universidad Nacional de Colombia. Guía de práctica clínica para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto y puerperio: sección 3. Infecciones en el embarazo: ruptura prematura de membranas (RPM). Rev Colombiana Obstetr Ginecol. 2015;66(4):263. http://dx.doi.org/10.18597/rcog.293

5. Crowley AE, Grivell RM, Dodd JM. Sealing procedures for preterm prelabour rupture of membranes. Cochrane Database Syst Rev. 2016;7(7):CD010218. http://doi.org/10.1002/14651858.CD010218.pub2

6. Crizostomo CD, Barros BBA, Luz DS. O perfil das mulheres com amniorrexe prematura em uma maternidade da rede pública estadual. Rev Interdiscipl. 2016;9(1):135-42.

7. Eleje GU, Ezugwu EC, Eke AC, Ikechebelu JI, Ezeama CO, Ezebialu IU, et al. Accuracy and response time of dual biomarker model of insulin-like growth factor binding protein- 1/alpha fetoprotein (Amnioquick duo+) in comparison to placental alpha-microglobulin-1 test in diagnosis of premature rupture of membranes. J Obstet Gynaecol Res. 2017;43(5):825-33. http://doi.org/10.1111/jog.13296

8. Packard RE, Mackeen AD. Labor induction in the patient with preterm premature rupture of membranes. Seminars Perinatol. 2015;39(6):495-500. https://doi.org/10.1053/j.semperi.2015.07.015

9. Santos CMC, Pimenta CAM, Nobre MRC. The PICO strategy for the research question construction and evidence search. Rev Latino-Am Enfermagem. 2007;15(3):508-11. https://doi.org/10.1590/S0104-11692007000300023

10. Pasquier JC, Claris O, Rabilloud M, Ecochard R, Picaud JC, Moret S, et al. Intentional early delivery versus expectant management for preterm premature rupture of membranes at 28–32 weeks’ gestation: A multicentre randomized controlled trial (Micado Study). Eur J Obstet Gynecol Reprod Biol. 2019;233:30-7. http://doi.org/10.1016/j.ejogrb.2018.11.024

11. Bond DM, Middleton P, Levett KM, van der Ham DP, Crowther CA, Buchanan SL, et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks’ gestation for improving pregnancy outcome. Cochrane Database Syst Rev. 2017;3(3):CD004735. https://doi.org/10.1002/14651858.CD004735.pub4

12. Bomba-Opoń D, Drews K, Huras H, Laudański P, Paszkowski T, Wielgoś M. Polish Gynecological Society Recommendations for Labor Induction. Ginekol Pol. 2017;88(4):224-34. http://doi.org/10.5603/GP.a2017.0043

13. Bertholdt C, Morel O, Dap M, Choserot M, Minebois H. Labor induction in indicated moderate to late preterm birth. J Matern Fetal Neonatal Med. 2020;33(1):157-61. http://doi.org/10.1080/14767058.2018.1487942

14. Thomson AJ, Royal College of Obstetricians and Gynaecologists. Care of women presenting with suspected preterm prelabour rupture of membranes from 24+0 weeks of gestation. BJOG. 2019;126(9):e152-66. http://doi.org/10.1111/1471-0528.15803

15. Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Ações Programáticas Estratégicas. Gestação de alto risco: manual técnico. Brasília: Ministério da saúde, 2012.

16. Lee J, Romero R, Kim SM, Chaemsaithong P, Park CW, Park JS, et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016;29(5):707-20. http://doi.org/10.3109/14767058.2015.1020293

17. Becker DA, Szychowski JM, Kuper SG, Jauk VC, Wang MJ, Harper LM. Labor Curve Analysis of Medically Indicated Early Preterm Induction of Labor. Obstet Gynecol. 2019;134(4):759-64. http://doi.org/10.1097/AOG.0000000000003467

18. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. http://doi.org/10.1002/14651858.CD004454.pub3

19. Abdali F, Taghavi S, Vazifekhah S, Behzad MN, Attari MMA. Effect of progesterone on latent phase prolongation in patients with preterm premature rupture of membranes. Acta Med Iran. 2017;55(12):772-8.

20. Combs CA, Garite TJ, Maurel K, Abril D, Das A, Clewell W, et al. 17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2015;213(3):364.e1-364.e12. http://doi.org/10.1016/j.ajog.2015.05.009

21. Hösli I, Sperschneider C, Drack G, Zimmermann R, Surbek D, Irion O, et al. Tocolysis for preterm labor: Expert opinion. Arch Gynecol Obstet. 2014;289(4):903-9. http://doi.org/10.1007/s00404-013-3137-9

22. Nijman TAJ, van Vliet EOG, Naaktgeboren CA, Oude Rengerink K, Lange TS, Bax CJ, et al. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;205:79-84. http://.doi.org/10.1016/j.ejogrb.2016.08.024